secwatch.observer — SEC 8-K summary
======================================

Issuer:     GELESIS HOLDINGS, INC. (—)
CIK:        0001805087
Form:       8-K
Filed at:   2023-05-03T23:59:59+00:00
Accession:  0000950170-23-017171
Event type: debt
Sentiment:  negative
Materiality: 0.80
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Gelesis issues $2M additional notes to PureTech, warrants at $0.0182/share; delisting from NYSE
--------------------------------------------------------------------------------

- Issued $2.0M additional convertible notes to PureTech Health on May 1, 2023; new warrants for 192,307,692 shares at $0.0182 exercise.
- Initial warrant amended to remove stockholder approval requirement due to NYSE delisting process.
- Notes maturity July 31, 2023, extendable to March 31, 2024 if $10M raised from other notes.
- Further note purchases contingent on OTC reclassification of Plenity and agreement on acquisition of Gelesis by PureTech.
- Most favored investor provision added: PureTech can demand amended terms if better deals offered to others.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1805087/000095017023017171/0000950170-23-017171-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1805087/000095017023017171/gls-20230501.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-017171

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer